NCT06602284View on ClinicalTrials.gov

A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Acne

Interventions

COMBINATION_PRODUCT

Dermapen 4™

Dermapen 4™ conjunction with MG-CLR

Trial Locations (1)

35209

Skin Wellness Dermatology, Birmingham

All Listed Sponsors

lead

Equipmed USA LLC

INDUSTRY